Navigation Links
BioLife Solutions Congratulates DCPrime on Its Approved Orphan Medicinal Product Application for DCOne™ Leukemia Vaccine
Date:2/6/2012

BOTHELL, Wash., Feb. 6, 2012 /PRNewswire/ --
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, today recognized its customer DCPrime, a Dutch clinical stage company, on receiving orphan drug designation by the Committee for Orphan Medical Products (COMP) of the European Medicines Agency of DCPrime's novel DCOne platform vaccine indicated for Acute Myeloid Leukemia (AML).

(Logo:  http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO)

"This orphan drug designation is a major step in DCPrime's work towards approval of our AML vaccine, and clearly reflects the COMP's view of the potential of this vaccine in improving survival of patients with AML," said DCPrime Chief Executive Officer and Chief Scientific Officer Dr. Ada Kruisbeek.  

Mike Rice, BioLife Chief Executive Officer, commented on DCPrime's selection of CryoStor by stating, "We congratulate Dr. Kruisbeek and her team on achieving this milestone.  We're pleased to see continued adoption of our novel biopreservation media products in cellular therapy and regenerative medicine applications. The biopreservation efficacy and quality and safety profile of our products are driving increased demand as the regulatory environment for reagents used in the manufacturing, transportation and clinical administrati
'/>"/>

SOURCE BioLife Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioLife Solutions Increases 2011 Financial, Scientific, Technical Support of the Regenerative Medicine Industry
2. BioLife Solutions Announces Record Quarterly Revenue
3. BioLife Solutions Announces Expanded Customer Base in the High Growth Regenerative Medicine Market
4. Independent Data Published on BioLife Solutions HypoThermosol® and CryoStor®
5. Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
6. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
7. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
8. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
9. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
10. DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0
11. EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 ... Devices Market by Type (Dermatology Treatment Devices, and Dermatology ... Microscopes]), by Application, by Geography - Analysis and Forecast ... to reach $11.88 billion by 2019, at a CAGR ... through the TOC of Global Dermatology Devices Market for ...
(Date:7/28/2015)... 2015 Transparency Market Research (TMR) has ... Cancer Diagnostics Market - Global Industry Analysis, Size, Share, ... According to this report, the global cancer diagnostics market is ... forecast period of 2014 to 2020. In 2013, the global ... expected to be worth US$168,649.3 million by 2020.The increasing prevalence ...
(Date:7/28/2015)... WESTFORD, Mass., July 28, 2015   Cynosure, ... manufactures and markets medical devices for aesthetic procedures ... results for the three months ended June 30, ... another quarter of double-digit growth, as revenues increased ... said Cynosure Chief Executive Officer Michael Davin. "While ...
Breaking Medicine Technology:Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 2Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 3Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 5Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 6Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 7Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 8Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 9Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 10Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 11Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 12Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 13
... Encouraging and Support Phase III Study, DEERFIELD, ... BAX ) and The Alzheimer,s Disease Cooperative Study ... multi-center U.S. Phase III study,evaluating the role of ... immunoglobulin preparation, for the,treatment of patients with mild ...
... 28 CuraGen Corporation,(Nasdaq: CRGN ) and ... initiation of patient dosing in a Phase I/II ... in combination with the anthracycline idarubicin for the,treatment ... being conducted at,multiple sites in the European Union. ...
Cached Medicine Technology:Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 2Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 3Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 4Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 5Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 6CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 2CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 3CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 4CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 5CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 6
(Date:7/28/2015)... ... 28, 2015 , ... opaJUMP! and O-PA! Performance Academy ... outcomes associated with its training methods. This company is also the first to ... conducted in early 2015, training yielded an average 80% improvement in functional health ...
(Date:7/28/2015)... ... July 28, 2015 , ... Master flutist and solo artist Gary ... around the world, in this collection of serene, restorative instrumental music. Tracks carefully ... yoga practice, for body work and more -- to help the listener deeply breathe ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Egg ... consider the procedure to help ensure future fertility. As Dr. Michael Kettel ... egg freezing is an option that wasn’t available for previous generations who had to ...
(Date:7/28/2015)... ... July 28, 2015 , ... According to Kxan on ... cycle of addiction in lab mice. The study involving isradipine has garnered national attention ... of helping their clients overcome drug and alcohol addictions. The study was conducted by ...
(Date:7/28/2015)... ... 2015 , ... On July 16th NPR reported needle exchange programs ... bills and laws revolving the implementation of a small pilot program in Miami-Dade county, ... continuing to hand out clean needles to drug users who are addicted to intravenously ...
Breaking Medicine News(10 mins):Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 2Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 3Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 5Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 6Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 7Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 2Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 3Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 4Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3Health News:Blood Pressure Medication May be the Key to Treating Addiction 2Health News:Blood Pressure Medication May be the Key to Treating Addiction 3Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 2Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 3
... Claims Processing and PaymentBROOMFIELD, Colo., March 11 ... LVLT ) today announced that it has ... management services company, to provide that company,s primary network ... Level 3 will deliver direct Internet access and voice ...
... Winners will be Awarded Travel to CCFA California EventNEW ... managing their everyday life can be a challenge, but ... help control their disease and live their lives. To ... inspire one another, the Crohn,s & Colitis Foundation, in ...
... Lewis in Urging Stockholders to Vote the GOLD CardCINCINNATI, ... ) announces that the independent proxy advisory firm PROXY ... and Glass Lewis & Co., LLC in recommending that ... and Board of Directors and reject all ...
... March 11 Universal Capital Management, Inc. ... business development company that provides management and ... is pleased to announce that one of ... acquired Professional Healthcare Billing Services (PHB) located ...
... validation for Postoperative Nausea and Vomiting (PONV)CORONA DEL MAR, ... 1983, making each patient,s oxygen status known on a ... of Anesthesiologists (ASA) say that all patients should have ... appear in the ASA Newsletter on their web site ...
... actually play a more sinister role in organ failure caused by ... ... 2009 -- Scientists at Children,s National Medical Center have ... from sepsis: platelets. , , , , ,The finding, published in ...
Cached Medicine News:Health News:Level 3 Provides Primary Connectivity for MDI Holdings 2Health News:Level 3 Provides Primary Connectivity for MDI Holdings 3Health News:Celebrating UC Success Contest Seeks to Educate and Inspire Ulcerative Colitis Patients 2Health News:Celebrating UC Success Contest Seeks to Educate and Inspire Ulcerative Colitis Patients 3Health News:Celebrating UC Success Contest Seeks to Educate and Inspire Ulcerative Colitis Patients 4Health News:Celebrating UC Success Contest Seeks to Educate and Inspire Ulcerative Colitis Patients 5Health News:Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors 2Health News:Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors 3Health News:Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors 4Health News:iVolution Medical Systems Acquires Professional Healthcare Billing Services 2Health News:iVolution Medical Systems Acquires Professional Healthcare Billing Services 3Health News:American Society of Anesthesiologists (ASA) - Myths About 'Never Ending Pursuit of Patient Safety and Satisfaction' Debunked 2Health News:Children's National Research Links Platelets to Sepsis-Related Organ Failure 2Health News:Children's National Research Links Platelets to Sepsis-Related Organ Failure 3
... The Mini-Sub cell GT system, ... and mini-gel caster, is used for ... acids in mini format agarose gels. ... 7 x 7 cm UV-transparent gel ...
... cell GT system, with 15 x 7 ... for submerged horizontal gel electrophoresis of nucleic ... system includes an electrophoresis cell, 15 x ... mini-gel caster, and two 1.5 mm fixed-height ...
... future generations. Most gels can be dried by ... our gel dryer, covering them with wet semi-permeable ... hold the cellophane flat. Tut's Tombs also produce ... area somewhat larger than the gel to be ...
... data for future generations. Most gels can be ... plate of our gel dryer, covering them with ... them to hold the cellophane flat. Tut's Tombs ... an open area somewhat larger than the gel ...
Medicine Products: